Target intelligence / Profile preview

Peroxiredoxin I (PRDX1)

Target
PRDX1
Molecular classification
Enzyme, Antioxidant enzyme, Peroxidase, 2-Cys peroxiredoxin family member
01

Overview

Peroxiredoxin I (PRDX1) is an abundant, highly conserved cysteine-dependent peroxidase enzyme and key member of the peroxiredoxin family. It reduces hydrogen peroxide, organic hydroperoxides, and peroxynitrite to protect cells from oxidative damage and regulate redox balance. PRDX1 is involved in cell signaling, especially in modulating peroxide-mediated signal transduction, and plays roles in cell differentiation, proliferation, and stress response. Dysregulation or altered expression of PRDX1 has important implications in cancer biology, inflammation, cardiovascular and neurodegenerative diseases. In addition to classical peroxidase activity, PRDX1 can function as a disulfide reductase, influencing processes such as motor neuron differentiation through interaction with proteins like GDE2.

Other names
PRDX1Prx IPeroxiredoxin-1
02

Mechanism of action

Reduction of peroxides and ROS (reactive oxygen species) via cysteine-dependent mechanisms. Regulatory modulation of cell signaling by oxidation state transfer to effector proteins. Disulfide reductase activity for other protein targets (e.g. GDE2).

03

Biological functions

Peroxide reduction (hydrogen peroxide, organic hydroperoxides, peroxynitrite)Antioxidant defenseRedox regulationSignal transduction (control of cytokine-induced peroxide levels)Regulation of cell differentiation, notably spinal motor neuron differentiation (by GDE2 activation)Cellular stress response
04

Disease associations

Cancer (regulation of cellular signaling and oxidative stress adaptation)InflammationNeurodegenerative disease (relevance in neuronal differentiation)Cardiovascular disease
05

Safety considerations

Overexpression in tumors may be associated with therapy resistance due to enhanced antioxidant defenseInhibition may risk increased oxidative damage and normal cell toxicity
06

Biomarkers

Elevated expression of Peroxiredoxin I is used as a biomarker in several cancers to predict oxidative stress adaptation and patient prognosis

Beyond the preview

Go deeper on Peroxiredoxin I (PRDX1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peroxiredoxin I (PRDX1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call